Seeking to treat the root of several aging-related diseases, the new clinical trial is testing whether medication can delay onset of certain illnesses, such as cancer, heart disease, and cognitive impairment.
By Liat Levy
The cultural fixation with youth has permeated industries from cosmetics, pharmaceuticals, food, supplements and more. We are frequently hearing that a magical cure is just around the corner.
Dr. Nir Barzilai
Professor Nir Barzilai, director and founder of the Institute for Aging Research at Yeshiva University’s Albert Einstein College of Medicine, has more reason than most to believe that this is not far from the truth. Continue Reading »
Although Israel is a global leader in cannabis research for medicinal use, many ill Israelis still face heavy bureaucracy trying to obtain the medical treatment.
By JUDY SIEGEL-ITZKOVICH
A Knesset loby for the use of medical cannabis has been established with Likud MK Sharren Haskel at its head, it was announced on Thursday. “It has become accepted that medical cannabis has significant health benefits and an important place in the development of the world of medicine,” Haskel said, “but there are many impediments to its use. The trend is to limit this development, even tough there are many seriously ill patients who need it.” Continue Reading »
Hebrew University of Jerusalem students are working on micro-antenna that can be inserted into the stomach to detect & treat cancers too small to be treated with available methods.
By Yori Yalon
Students at the Hebrew University in Jerusalem are developing an innovative micro-antenna able to focus radiation at tiny tumors in the digestive tract.
An image of the innovative new antenna, which will revolutionize treatment of small tumors
Continue Reading »
The university noted that there is currently no treatment for tumors in the early stages of cancer, when they measure less than 5 millimeters (0.19 inches). The new antenna would eliminate the need to wait for the tumors to grow big enough to be treated, as well as eliminate the need for complicated, invasive surgery.
Israel’s Police Chief Danino made surprising comment while speaking to high school students in Beit Shemesh, acknowledging, “…More citizens are asking that the use of Cannabis be legalized.”
The Israeli government and police should reexamine their policies on the use of cannabis and study how other countries are dealing with the matter, National Police Chief Yohanan Danino said Wednesday.
National Police Chief Yochanan Danino – Photo: Marc Israel Sellem
“I think the time has come for the Israel police, together with the state, to re-examine their stance on Cannabis. I think we must sit and study what’s happening around the world [with Cannabis].” Continue Reading »
Israeli firm BrainStorm reports final results in its clinical trial of stem cell treatment NurOwnat, at Jerusalem‘s Hadassah Medical Center, showing improvement in 92% of participants.
Israel’s BrainStorm Cell Therapeutics said final results from a clinical trial of its adult stem cell treatment in amyotrophic lateral sclerosis (ALS) were positive, with most patients showing a slowing in the disease’s progression.
According to the ALS Association, 5,600 people in the United States are diagnosed each year with the neurodegenerative disease, which has severely disabled British physicist Stephen Hawking.
Illustrative (right): Shutterstock
A single dose of the stem cell treatment called NurOwn was administered in a mid-stage phase 2a trial in 14 patients with ALS, also known as Lou Gehrig’s Disease, at Hadassah Medical Center in Jerusalem. Continue Reading »
WATCH: An Israeli biotechnology company has developed a vaccine for cancer, which is not designed to treat the illness – but to attack and kill the cells preventing it from returning.
By Jonathan Neff, NoCamels.com
There’s no doubt that cancer is one of the world’s most vicious diseases. For decades, scientists have been trying to find a cure for cancer, a terminal illness that kills 8 million people worldwide every year. With 14 million new cancer cases diagnosed around the globe every year, according to the World Health Organization, the need for prevention is vital. Now, an Israeli biotechnology company is developing a vaccine for cancer, which is not designed to treat the disease – but to prevent it from returning. Continue Reading »
Currently, Jewish women are only tested for the BRCA1 & BRCA2 gene mutations if they report high incidences of cancer among their female relatives.
All Ashkenazi Jewish women should be routinely tested for two genetic mutations, even if they do not have a family history of breast cancer, a leading researcher said in an article published on Friday.
A patient and a technician during mammogram screening. – Photo: AP
The connection between harmful mutations in the tumor suppressor genes BRCA1 and BRCA2 and hereditary breast-ovarian cancer is well-established, but women are typically only screened if they report high incidences of cancer among close female relatives. Continue Reading »
When the new Israeli product from IonMed receives final marketing approval, surgeons will have a revolutionary product available for scar-free incision closure.
Women giving birth by Caesarean section could be the first to benefit from a revolutionary Israeli invention for closing surgical incisions without stitches or staples. The technique also promises to leave patients less prone to infection and scarring.
The product provides a next-generation alternative to staples and stitches. – Israel21c
BioWeld1, a unique trademarked product from Israeli startup IonMed, welds surgical incisions using cold plasma.
Plasma is a gas in which a certain proportion of the particles are ionized. Continue Reading »
Professors from Tel Aviv University’s Sackler Faculty of Medicine and the Technion produced the NaNose: a Breathalyzer test that ‘smells’ lung cancer in its early stages of development.
By NoCamels Team
Lung cancer is considered the deadliest of all cancers, the culprit for over 27 percent of all cancer deaths in the U.S. annually. However, the reason for this worrisome statistic derives not from the fact that it is more common, but from the challenges of detecting its deadly progression. Lung cancer attacks without leaving any fingerprints, quietly afflicting its victims and metastasizing uncontrollably — to the point of no return. Continue Reading »
Molecule triggers reaction in crucial enzyme allows cancer-infected cells to become more receptive to accepting treatment & enhances the effectiveness of cancer-treating drugs.
By Tova Dvorin
Hebrew University researchers have pinpointed the process by which tumors become resistant to cancer treatments, according to NoCamels, paving the way for significant changes in cancer-treating drugs.
While Israel has developed several anti-cancer drugs, not every patient will benefit from every drug; the correct cancer treatment for any given person must be individualized. Research has thus focused heavily on determining why certain tumors reject specific treatments – and how to universalize anti-cancer drugs to become more and more accessible. Continue Reading »
Mango, the 19 year old Israeli born brown bear, was treated at the Ramat Gan Zoological Park for a painful slipped disc.
Mango the brown bear was clearly in pain, as his keepers at Israel’s Ramat Gan Zoological Park observed some three weeks ago. He was eating well, but his walk had slowed and he clearly didn’t like getting up. Sure, there was clearly a problem, but just try asking a bear where it hurts.
Mango the bear undergoes surgery in Ramat Gan – Photo: AFP
After a few days with no improvement, the zoo called in the A-team: a team of experts from the Hebrew University of Jerusalem, headed by Merav Shamir, an expert on veterinary neurology and neurosurgery. Continue Reading »
The research is 2-fold: to provide a specific target for anti-cancer drugs to increase their therapeutic benefits, & to reduce the toxic side effects of anti-cancer therapies.
By NoCamels Team
Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.
Now Prof. Dan Peer of Tel Aviv University’s Department of Cell Research and Immunology has proposed a new strategy to tackle an aggressive subtype of ovarian cancer using a new nanoscale drug-delivery system designed to target specific cancer cells. Continue Reading »